0001209191-17-046685.txt : 20170731
0001209191-17-046685.hdr.sgml : 20170731
20170731162955
ACCESSION NUMBER: 0001209191-17-046685
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170727
FILED AS OF DATE: 20170731
DATE AS OF CHANGE: 20170731
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: OBrien Christopher Flint
CENTRAL INDEX KEY: 0001343124
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 17993356
MAIL ADDRESS:
STREET 1: 12790 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330525145
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-27
0
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001343124
OBrien Christopher Flint
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
0
1
0
0
Chief Medical Officer
Common Stock
2017-07-27
4
M
0
8734
8.65
A
57707
D
Common Stock
2017-07-27
4
S
0
8734
50.00
D
48973
D
Non-Qualified Stock Option
8.65
2017-07-27
4
M
0
8734
8.65
D
2023-01-10
Common Stock
8734
77266
D
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
Option granted January 10, 2013 and vested over 4 years.
/s/Darin Lippoldt, Attorney-In-Fact
2017-07-31